Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ

$93.85

$-0.01

(-0.01%)

Pre-Market

Mirum Pharmaceuticals, Inc. (MIRM) Live Price Chart

Last updated: ⁦2026-09-16 09:04:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Mirum Pharmaceuticals, Inc. (MIRM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $93.85, with a market capitalisation of $6.28B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $63.23 to $130.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$6.28B
Open	$93.86
Day's High	$130.00
Day's Low	$6.51
Previous Close	$93.90
Volume	2.25K
Average Volume	771.24K
P/E Ratio	--
52-Week High	$130.00
52-Week Low	$63.23
Dividend Yield	--
Earnings Date	--

Mirum Pharmaceuticals, Inc. (MIRM) Pre-Market Stock Price

Mirum Pharmaceuticals, Inc. (MIRM) is trading at $93.85 in pre-market trading as of 2026-09-16 08:37:00, down 0.05% ($0.05) from the previous close of $93.90

Pre-market trading shows how investors are pricing MIRM before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Mirum Pharmaceuticals, Inc. (MIRM) 7-Day Stock Price Change

Over the past seven days, Mirum Pharmaceuticals, Inc. (MIRM) moved from $100.90 to $93.85, representing a decline of 6.99% ($7.05).

The stock traded between $93.57 and $103.28 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 568.08 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

MIRM 52-Week Price Position

Position in Range: 45.9%

52W Low$63.23

52W High$130.00

MIRM is currently trading at $93.85, placing it 45.9% of the way from its 52-week low of $63.23 to its 52-week high of $130.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Mirum Pharmaceuticals, Inc. (MIRM)?

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Mirum Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	433
Exchange	NASDAQ
Company Website	https://www.mirumpharma.com

How to Buy Mirum Pharmaceuticals, Inc. (MIRM) Stock on MEXC

Eligible investors can buy real shares of Mirum Pharmaceuticals, Inc. (MIRM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MIRM and Place Your Order

Open the RealStocks trading page and search for MIRM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Mirum Pharmaceuticals, Inc. (MIRM) stock price today?

Mirum Pharmaceuticals, Inc. (MIRM) is currently trading at $ 93.85, down 0.05% ($0.05) from the previous close of $ 93.90. Intraday prices update in real time during regular trading hours.

2.Is MIRM stock going up or down today?

As of 2026-09-16 08:37:00, MIRM is trading at $ 93.85, down 0.05% ($0.05) from its previous close of $ 93.90. The stock has traded between $ 6.51 and $ 130.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is MIRM pre-market price?

As of 2026-09-16 08:37:00, MIRM is trading at $ 93.85 in pre-market trading, down 0.05% ($0.05) from the previous close of $ 93.90. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MIRM after-hours price?

As of 2026-09-16 08:37:00, MIRM is trading at $ 93.86 in after-hours trading, down 0.04% ($0.04) from the regular-session close of $ 93.90. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MIRM stock trading now?

MIRM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MIRM sit relative to its 52-week high and low?

Over the past 52 weeks, MIRM has traded between a low of $ 63.23 and a high of $ 130.00. At $ 93.85, the stock is positioned 45.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Mirum Pharmaceuticals, Inc. in?

Mirum Pharmaceuticals, Inc. (MIRM) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Mirum Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Mirum Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 6.28B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MIRM valued in terms of P/E ratio and EPS?

MIRM trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -13.25. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Mirum Pharmaceuticals, Inc. pay a dividend?

Mirum Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.